Data / Research funding / Texas / Nanoscope Technologies, LLC
Nanoscope Technologies, LLC: 5 NIH awards ($6.7M), fiscal years 2021 to 2026
Nanoscope Technologies, LLC in Arlington, TX is funded under 5 NIH awards ($6.7M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- H6DNZXT5MMT1
- State
- Texas
Awards
5 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Mechanosensitive Channel based Pressure-Modulating Gene Therapy for Glaucoma Treatment | NIH | National Eye Institute | 2022 to 2023 | $1,592,229 | September 30, 2022 | August 31, 2025 | DIBAS, ADNAN ISMAIL | reporter.nih.gov |
| Sonogenetic Restoration of Vision for Retinitis Pigmentosa | NIH | National Eye Institute | 2024 to 2025 | $1,571,637 | May 1, 2024 | April 30, 2028 | MOHANTY, SAMARENDRA KUMAR | reporter.nih.gov |
| Ambient light activatable opsin based therapy for age-related macular degeneration | NIH | National Eye Institute | 2021 to 2022 | $1,487,322 | September 1, 2015 | February 29, 2024 | MOHANTY, SAMARENDRA KUMAR | reporter.nih.gov |
| Targeted Nano-enhanced Optical Delivery of opsin for dry-AMD therapy | NIH | National Eye Institute | 2021 to 2022 | $1,334,846 | June 1, 2020 | May 31, 2025 | MOHANTY, SAMARENDRA KUMAR | reporter.nih.gov |
| Bioluminescent Multi-Characteristic Opsin for simultaneous optical stimulation and large-scale monitoring of the visual system | NIH | National Eye Institute | 2021 to 2022 | $751,750 | September 30, 2018 | May 31, 2023 | MOHANTY, SAMARENDRA KUMAR | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2025 | 1 | $786,257 | 0 | $0 |
| 2024 | 1 | $785,380 | 0 | $0 |
| 2023 | 1 | $875,350 | 0 | $0 |
| 2022 | 4 | $2,486,779 | 0 | $0 |
| 2021 | 3 | $1,804,018 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.867 | November 18, 2026 | Not listed | Same assistance listing 93.867 as 5 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.867 | November 18, 2026 | Not listed | Same assistance listing 93.867 as 5 awards here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.867 | November 24, 2026 | Not listed | Same assistance listing 93.867 as 5 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.867 | December 3, 2026 | Not listed | Same assistance listing 93.867 as 5 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.867 | December 4, 2026 | Not listed | Same assistance listing 93.867 as 5 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.867 | January 5, 2027 | Not listed | Same assistance listing 93.867 as 5 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.867 | January 5, 2027 | Not listed | Same assistance listing 93.867 as 5 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.867 | January 7, 2027 | $375,000 | Same assistance listing 93.867 as 5 awards here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.867 | January 15, 2027 | $350,000 | Same assistance listing 93.867 as 5 awards here |
| Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) | PAR-24-268 | NIH | 93.867 | January 27, 2027 | $500,000 | Same assistance listing 93.867 as 5 awards here |
| BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) | RFA-NS-24-031 | NIH | 93.867 | January 28, 2027 | $750,000 | Same assistance listing 93.867 as 5 awards here |
| BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) | RFA-MH-26-170 | NIH | 93.867 | February 8, 2027 | Not listed | Same assistance listing 93.867 as 5 awards here |
| BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) | RFA-DC-27-004 | NIH | 93.867 | February 11, 2027 | $700,000 | Same assistance listing 93.867 as 5 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.867 | February 11, 2027 | $775,000 | Same assistance listing 93.867 as 5 awards here |
| Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) | PAR-27-081 | NIH | 93.867 | March 5, 2027 | Not listed | Same assistance listing 93.867 as 5 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.867 | April 5, 2027 | Not listed | Same assistance listing 93.867 as 5 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.867 | April 5, 2027 | Not listed | Same assistance listing 93.867 as 5 awards here |
| Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) | PA-24-191 | NIH | 93.867 | May 7, 2027 | Not listed | Same assistance listing 93.867 as 5 awards here |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | 93.867 | May 7, 2027 | Not listed | Same assistance listing 93.867 as 5 awards here |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | 93.867 | May 8, 2027 | Not listed | Same assistance listing 93.867 as 5 awards here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.